GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kohjin Bio Co 177A.T · JPY

N/A · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

705

+3.07%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Kohjin Bio Co — daily TSE:177A

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Kohjin Bio Co on TradingView ↗
Market value
¥3.60bn
Last close × shares
Volume
2k
Shares, 9 Nov 2026
Price to earnings
4.6
Dividend yield
2.81%

About Kohjin Bio Co

Its shares trade on Tokyo Stock Exchange under the ticker 177A.T. It has been listed since 25 April 2024. In the fiscal year to 31 March 2025, it reported revenue of ¥5.21bn and net income of ¥794.8m. At that date it held total assets of ¥9.07bn and shareholders' equity of ¥5.78bn.

Kohjin Bio Co Ltd is a JP-based company operating in industry. The company is headquartered in Sakado-Shi, Saitama-Ken. The company went IPO on 2024-04-25. Kohjin Bio Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of bacterial testing media, in vitro diagnostic drugs, cell culture media, as well as contract cell processing. The firm operates through three segments. The Tissue Culture business segment develops, manufactures, and sells tissue culture media, including serum-free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions at facilities that have obtained permission to manufacture specified cell products based on the Regenerative Medicine Safety Act.

Figures and description from our data supplier, not checked against the company's own report.

More about Kohjin Bio Co →

Latest on Kohjin Bio Co

Our reporting

We have not reported on Kohjin Bio Co yet.

Next results

13 Nov 2026

Due on 13 Nov 2026.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Kohjin Bio Co's ticker?

Kohjin Bio Co trades as 177A.T on Tokyo Stock Exchange, under ISIN JP3283630006.

What was Kohjin Bio Co's last closing price?

705 on 9 Nov 2026. The figure is in JPY and is never converted.

When does Kohjin Bio Co next report results?

Results are expected on 13 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.